TAYSHA GENE THERAPIES INC holding history
As of Nov. 6, 2026 (UTC)
| Dec. 31, 2025 | 156,586 | $861,223 | 0.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 319,748 | $1,429,274 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 489,219 | $3,331,581 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 4, 2026 |
3 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.